GSK Requesting Re-Issuance Of Advair Patent
This article was originally published in The Pink Sheet Daily
Executive Summary
GlaxoSmithKline will apply to the Patent & Trademark Office for re-issuance of an Advair patent that expires in September 2010, the company's second quarter earnings release says